Advertisement

Topics

Illumina, Inc. Company Profile

04:45 EST 19th February 2019 | BioPortfolio

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.


News Articles [94 Associated News Articles listed on BioPortfolio]

Illumina: Profiteur des Diagnostik-Booms

Kulmbach (www.aktiencheck.de) - Illumina-Aktienanalyse von "Der Aktionär": Michel Doepke, Redakteur des Anlegermagazins "Der Aktionär", nimmt in einer aktuellen Aktienanalyse die Aktie von Illumina....

Pacific Biosciences rockets after DNA sequencing giant Illumina buys it for $1.2 billion

Illumina needs a technology like Pac Bio to increase their capabilities and stay dominant

Illumina -- LATEST 1

BIO's preferred Gene Sequencing Solutions provider, Illumina, offers a free learning opportunity with a recorded webinar, "Th -More- 

Illumina to buy Pacific Biosciences for $1.2 billion

The $8 per share deal will allow Illumina to tap into the long-read sequencing market, while also heading off competition from other firms, analyst writes.

Illumina Set to Acquire “Long-Read” DNA Sequencer PacBio for $1.2B

DNA sequencing giant Illumina is shoring up its position in genetic research through a cash deal to acquire Pacific Biosciences for approximately $1.2 billion. Under the agreement, Illumina (NASDAQ: I...

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction....

Illumina Adds Long-Read Capabilities with Planned $1.2B Acquisition of PacBio

Illumina has agreed to acquire Pacific Biosciences for approximately $1.2 billion, in a deal designed to expand the sequencing giant’s offerings with PacBio’s long-read sequencing technologies. ...

Illumina To Acquire Pacific Biosciences At $8.00/shr

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) and Pacific Biosciences (PACB) announced an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in a...

Drugs and Medications [0 Results]

None

PubMed Articles [46 Associated PubMed Articles listed on BioPortfolio]

Illumina midi-barcodes: quality proof and applications.

DNA barcoding constitutes a supplemental genetically based characterization tool for the identification of species. Traditionally, the barcodes are generated with a length of 650 bp using standardiz...

Simulating Illumina Metagenomic Data with InSilicoSeq.

The accurate in-silico simulation of metagenomic datasets is of great importance for benchmarking bioinformatics tools as well as for experimental design. Users are dependant on large-scale simulation...

Illumina swallows PacBio in long shot for market domination.

Ion Torrent and lllumina, two complementary RNA-seq platforms for constructing the holm oak (Quercus ilex) transcriptome.

Transcriptome analysis is widely used in plant biology research to explore gene expression across a large variety of biological contexts such as those related to environmental stress and plant-pathoge...

Cyanobiont diversity in six Azolla spp. and relation to Azolla-nutrient profiling.

Illumina-Miseq-based cyanobiont diversity and biomass were analyzed in six Azolla spp. Results revealed that 93-98% of total operational taxonomic units (OTUs) belong to Nostacaceae followed by Cylind...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

The ILLUMINA Study. (ILLUMINA)

The aim of the prospective, multicentre, single-arm study is to assess safety and efficacy of a drug eluting stent in Nitinol alloy (NiTiDES) in term of vessel patency and composite event-...

Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion

The aim of this study is to investigate whether the microbiota in the upper respiratory tract (nasopharynx, adenoids and middle ear fluid) of otitis media with effusion (OME) patients is c...

Epigenetic Biomarker for Osteosarcoma

hMe-Seal is a low-input whole-genome cell-free 5hmC sequencing method based on selective chemical labeling. It uses β-glucosyltransferase (βGT) to selectively label 5hmC with a biotin vi...

Comprehensive DNA Methylation Profiling in Crohn's Disease

Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed i...

Nutritional Intake and Gut Microbiome

Pediatric obesity has been increasing in prevalence, but concerns have been raised around the world because no treatment has been found. Recently, however, research on gut microbiome has b...

Companies [14 Associated Companies listed on BioPortfolio]

Illumina

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our tec...

Illumina Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and functi...

GRAIL

GRAIL is focused on detecting cancer at an early-stage, when it can be cured. The company secured over $100 million in Series A financing from Illumina, Inc. and ARCH Venture Part...

Illumina, Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and ...

bioMérieux & Illumina

More Information about "Illumina, Inc." on BioPortfolio

We have published hundreds of Illumina, Inc. news stories on BioPortfolio along with dozens of Illumina, Inc. Clinical Trials and PubMed Articles about Illumina, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Illumina, Inc. Companies in our database. You can also find out about relevant Illumina, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record